Dr Reddys Laboratories Share Price Today - Live Blog for December 12, 2025

Dr Reddys Laboratories Ltd's share price has fallen by -0.08%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,279.50, and market participants are assessing the implications. The stock has a PE ratio of 18.5200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.11% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,279.65 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,278.40. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.5200, while the industry's PE ratio is 32.9342.

After a significant 0.11% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,276.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,275.60. Investors should examine the factors driving this decline. The stock's PE ratio is 18.5200, whereas the industry PE ratio stands at 32.9342.

Dr Reddys Laboratories Ltd witnessed a -0.06% drop in its share price and is currently trading at ₹1,275.60. With the stock's PE at 18.5200 and the industry PE at 32.9342, investors are weighing their options.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.14% recently. As of now, this stock is actively trading at a current market price of ₹1,276.35 per share, attracting attention from investors.

The stock of Dr Reddys Laboratories Ltd is facing a -0.07% decline and is currently trading at ₹1,274.55 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd plunged by -0.13%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,275.10, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.09%, reaching the current market price of ₹1,276.80. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a notable 0.09% surge in its share price and is presently trading at ₹1,275.60, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd suffered a -0.01% drop, and it's now trading at ₹1,274.45 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.05% drop, and it's now trading at ₹1,274.60 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.13% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,275.20. The stock is currently trading at a PE of 18.5200, while the industry PE is 32.9342, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.07% upswing, and it's currently trading at ₹1,276.90 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.02% upswing and is currently trading at ₹1,273.25, indicating strong market sentiment.

Dr Reddys Laboratories Ltd witnessed a -0.01% drop in its share price and is currently trading at ₹1,273.70. With the stock's PE at 18.5200 and the industry PE at 32.9342, investors are weighing their options.

Dr Reddys Laboratories Ltd's shares experienced a 0.30% uptick, and they are currently valued at ₹1,273.25, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at ₹1,269.50. The stock maintains a PE of 18.5200, while the industry PE is 32.9342, prompting discussions about its valuation.

With a remarkable 0.06% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,271.35. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.5200, while the industry's PE ratio is 32.9342.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.02%. At this moment, it's actively trading at ₹1,270.70, presenting an enticing opportunity for those in the market.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,270.70 per share. Investors are taking notice of this upward momentum.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.06% in its share price, and it currently trades at ₹1,271.10 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

With a -0.17% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,271.90. The stock is currently trading at a PE of 18.5200, while the industry PE is 32.9342, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock has surged by 0.16%, and it is currently trading at ₹1,274.05. Additionally, the stock maintains a PE ratio of 18.5200, while the industry PE is 32.9342.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.17% increase and currently trading at ₹1,272.15 per share. Investors are taking notice of this upward momentum.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.17% boost, with the current market value at ₹1,272.15 per share. This surge has not gone unnoticed by investors.